News Data builds behind Moderna's skin cancer vaccine Five-year results with Moderna/MSD's melanoma jab show a 49% reduction in disease progression or death, boding well for phase 3 data later this year.
News Could Alzheimer's be predicted with a finger-prick test? An international trial has started to see if a simple finger-prick blood test could predict Alzheimer's before symptoms start.
News J&J builds case for earlier Tecvayli use in multiple myeloma Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma.
News JPM: Is the UK's clinical trials sector turning a corner? New data from the UK medicines regulator has shown an increase in clinical trial activity in the country, after years of decline.
R&D Sponsored Obesity, complexity, and the lab: What 2025 taught us, and w... The complexity of working with the patient population in obesity continues to challenge traditional trial design. hVIVO looks to the year ahead.
News Hutchmed scores with drug for rare autoimmune disease Hutchmed is preparing to file for approval of its drug for the rare disorder wAIHA in China, after chalking up a win in a pivotal phase 2/3 trial.
News FDA follows experts' advice and blocks Capricor DMD therapy The FDA has dashed Capricor's hope of getting approval for its cell therapy for Duchenne muscular dystrophy, wreaking havoc with its share price.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.